Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround

As struggling drugstore chains work to regain their footing, Walgreens is doubling down on automation.  The company is expanding the number of retail stores served by its micro-fulfillment centers, which use robots to fill thousands of prescriptions for patients who take medications to manage or treat diabetes, high blood pressure and other conditions.  Walgreens aims to free up time for…

Which Will Hit First: SPX 6100 or SPX 5100?

Last Friday, the S&P 500 finished the week just below 5700. The question going into this week was, “Will the S&P 500 get propelled above the 200-day?” And as I review the evidence after Friday’s close, I’m noting that the SPX is almost exactly where it was one week ago! That’s right–after all the headlines, tariff tantrums,…

Recession Ahead? Sector Rotation Model Warns of Rising Risk

Is a recession coming? In this video, Julius breaks down the latest updates to his powerful Sector Rotation Model, analyzing four key macroeconomic indicators and their impact on sector performance. This video was originally published on May 9, 2025. Click on the icon above to view on our dedicated page for Julius. Past videos from Julius can be…

Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development

finlay minerals ltd. (TSXV: FYL) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’) is pleased to announce that it has appointed Robert F. Brown as Executive Chairman of the Board, and Ilona Barakso Lindsay as President & Chief Executive Officer. Mr. Brown and Ms. Lindsay formerly held the positions of President & CEO, and Vice President Corporate…

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee

DSMC concluded that Phase 1 study may continue as planned without any modifications On track to complete the enrollment of the first two cohorts by mid-2025 Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, announced today…